This opportunity is no longer accepting applications.
grant RFA-DA-25-013

Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)

This grant opportunity aims to support research on how inflammasomes contribute to brain damage caused by drug use and HIV infection. The goal is to understand how these inflammasomes affect immune activation when HIV and drug use are involved. Findings could help identify biomarkers and immune cells relevant to HIV in people who use drugs, and lead to new treatments targeting inflammasome act…

The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune ac…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Opportunity Released: October 17, 2023
Open for Submission: October 17, 2023
Submission Deadline: March 13, 2025
Application Window Closes: March 13, 2025

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.